MetaCap

Trupanion (TRUP) vs Veracyte (VCYT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Trupanion (TRUP) has outperformed Veracyte (VCYT) over the past year, losing 0.9% versus a loss of 42.9%. Over five years, VCYT leads with a -39.5% price change compared with -72.0% for TRUP. Veracyte is the larger company by market cap ($2.03 billion vs $1.54 billion), about 1.3 times the size.

On valuation, Trupanion trades at a lower forward P/E (8.1x vs 16.2x for Veracyte). Veracyte converts more of its revenue into profit, with a net margin of 12.8% versus 1.4%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

TRUP-0.95%VCYT-42.90%
+42%-4%-50%
Nov 21, 20251 yearNov 20, 2026
TRUP-73.95%VCYT-49.03%
+28%-31%-91%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

TRUP versus VCYT key metrics
MetricTRUPVCYT
Share price$35.56$25.13
Market cap$1.54B$2.03B
1-day change-0.86%+0.36%
YTD return-4.84%-40.31%
1-year return-0.95%-42.90%
5-year return-71.95%-39.53%
P/E ratio (TTM)58.3016.32
Forward P/E8.1416.15
EPS (TTM)$0.61$1.54
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$1.44B$517.14M
Revenue growth (YoY)+11.95%+16.01%
Net income (latest FY)$19.43M$66.35M
Gross margin16.05%70.10%
Operating margin0.96%11.17%
Net margin1.35%12.83%
52-week high$38.87$60.91
52-week low$21.16$21.91
Distance from 52-week high-8.52%-58.74%
Analyst consensusbuybuy
Avg. price target upside+3.35%+77.48%
Average volume443.82K1.89M
Shares outstanding43.26M80.70M
Employees1,121755
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • TRUP has outperformed VCYT by 42.0 percentage points over the past year.
  • Trupanion trades at a higher earnings multiple (58.3x vs 16.3x trailing P/E).
  • Veracyte is more profitable, keeping 12.8 cents of every revenue dollar as net income versus 1.4 cents for Trupanion.

About Trupanion

TRUP stock →

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on subscription basis in the United States, Canada, and Continental Europe. The company operates in two segments, Subscription Business and Other Business.

Health Care · Medical Specialities · 1,121 employees

About Veracyte

VCYT stock →

Veracyte, Inc. operates as a diagnostics company in the United States and internationally.

Health Care · Medical Specialities · 755 employees

TRUP vs VCYT FAQ

Which is bigger, Trupanion or Veracyte?

Veracyte (VCYT) is larger, with a market capitalization of $2.03B compared with $1.54B for Trupanion (TRUP).

Which stock has performed better over the past year, TRUP or VCYT?

TRUP returned -0.95% over the past 12 months, compared with -42.90% for VCYT (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, TRUP or VCYT?

VCYT has the lower trailing P/E at 16.3, versus 58.3 for TRUP. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Trupanion and Veracyte in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons